Citadel Advisors - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is and the CUSIP is 88322Q958. A total of 2 filers reported holding TG THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2015$51,000
-67.1%
4,300
-72.1%
0.00%
Q3 2015$155,000
-10.9%
15,400
+46.7%
0.00%
Q2 2015$174,000
-27.8%
10,500
-32.7%
0.00%
Q1 2015$241,000
+12.6%
15,600
+15.6%
0.00%
Q4 2014$214,000
+210.1%
13,500
+107.7%
0.00%
Q3 2014$69,000
-18.8%
6,500
-28.6%
0.00%
Q2 2014$85,000
+203.6%
9,100
+122.0%
0.00%
Q1 2014$28,000
+55.6%
4,100
-12.8%
0.00%
Q4 2013$18,0004,7000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 12,500$107,0000.00%
View complete list of TG THERAPEUTICS INC shareholders